Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 64
Filtrar
Más filtros

Banco de datos
País/Región como asunto
Tipo del documento
Intervalo de año de publicación
1.
Cancer Invest ; 42(6): 478-490, 2024 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-38845533

RESUMEN

Biliary dysbiosis is associated with gallbladder cancer (GBC). We aimed to look for biliary bacteria specifically detected in GBC patients. We used 16S rRNA-based metagenomic analysis to elucidate biliary microbiota in 30 GBC and 30 gallstones-associated chronic cholecystitis patients. Relative abundance of five genera, Streptococcus, Enterococcus, Halomonas, Escherichia and Caulobacter was significantly associated with GBC. Of 15-species, 7 were detected significantly higher in GBC, Streptococcus anginosus, Streptococcus constellatus, Streptococcus intermedius, Actinomyces bowdenii, Actinomyces israelii, Actinomyces gerencseriae, and Escherichia fergusonii were biosafety level-2 infectious bacteria; other 8 species were biosafety level-1 bacteria. These bacterial species may be involved in pathogenesis of GBC.


Asunto(s)
Colecistitis , Neoplasias de la Vesícula Biliar , Cálculos Biliares , Metagenómica , Humanos , Neoplasias de la Vesícula Biliar/microbiología , Colecistitis/microbiología , Cálculos Biliares/microbiología , Femenino , Masculino , Metagenómica/métodos , Persona de Mediana Edad , Anciano , ARN Ribosómico 16S/genética , Enfermedad Crónica , Bacterias/genética , Bacterias/clasificación , Bacterias/aislamiento & purificación , Microbiota , Adulto , Disbiosis/microbiología
2.
World J Surg ; 45(4): 971-980, 2021 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-33454794

RESUMEN

BACKGROUND: Biliary injury is the most feared complication of laparoscopic cholecystectomy (LC). This study aimed to assess the awareness of culture of safety in cholecystectomy (COSIC) concept among the surgical residents in India. METHODS: A manual survey was conducted among general surgery residents attending a postgraduate course. Survey consisted of questions pertaining to knowledge of various aspects of COSIC, e.g., the critical view of safety (CVS). RESULTS: With a response rate of 51%, 259 residents were included in this study. They had more exposure to LC (63.3% assisted / performed > 15 LC) than to open cholecystectomy (60.6% assisted / performed ≤ 10 open cholecystectomy). The majority (80.2%) clearly differentiated Calot triangle from the hepatocystic triangle (HCT). However, 25.8% could not correctly define HCT. The majority (88.5%) had seen the Rouviere's sulcus during LC. While almost all (98.4%) respondents claimed to know about the segment 4, only 41.9% could correctly describe it. Awareness of the correct direction of the gallbladder retraction was lower for the infundibulum (53.5%) than for fundus (89.2%). The majority (88.3%) claimed to know CVS but only 11.5% knew it correctly, and 15.1% described > 3 components. The majority (78.7%) practiced to identify the cystic duct-common bile duct junction. Awareness was low for time-out (28.1%), intraoperative cholangiography (20.6%), bailout techniques (18.9%), and for overall COSIC concept (15.7%). CONCLUSIONS: Knowledge of COSIC among surgical residents seems to be suboptimal, especially for the CVS, time-out, bailout techniques, and overall concept of COSIC. Strategies to educate them more effectively about COSIC are highly imperative to train them well for future practice.


Asunto(s)
Colecistectomía Laparoscópica , Internado y Residencia , Colangiografía , Colecistectomía , Colecistectomía Laparoscópica/efectos adversos , Humanos , India
3.
J Minim Access Surg ; 15(3): 273-274, 2019.
Artículo en Inglés | MEDLINE | ID: mdl-30106027

RESUMEN

Bile duct injury (BDI) is not uncommon during laparoscopic cholecystectomy (LC). Intra-operative cholangiography (IOC) has been recommended to reduce the risk of BDI during LC. Facilities for IOC are, however, scarcely available in India. The author suggests 'in vicinity colleaguography' (IVC) - opinion of a surgical colleague in vicinity - as an easy alternative to IOC.

6.
J Cancer Res Ther ; 20(1): 349-357, 2024 Jan 01.
Artículo en Inglés | MEDLINE | ID: mdl-38554345

RESUMEN

AIM: Gallbladder cancer (GBC) is usually diagnosed in advanced stages with poor survival. The molecular mechanisms of GBC still remain unexplored. Several angiogenesis factors play a pivotal role in tumor progression. We aimed to study the expression of VEGF, PDGF-B, and human epidermal growth factor receptor 2 (HER2/neu) and its association with clinicopathological features and survival in GBC. MATERIALS AND METHODS: VEGF, PDGF-B, and HER2/neu expression was studied by immunohistochemistry (IHC) after histological evaluation in 91 GBC cases. The relationship between these markers and clinicopathological features and survival was explained through the Cox regression model and Kaplan-Meier method. RESULTS: VEGF, PDGF-B, and HER2/neu overexpressed in 45, 79, and 68% GBC cases, respectively. VEGF was significantly overexpressed in GBC without gall stones (GS) (p = 0.007) and with moderately and poorly differentiated tumors (p = 0.012). HER2/neu was significantly overexpressed in GBC with GS (p = 0.022). Median overall survival (OS) was 39 months (95% CI: 23-55). In univariate analysis, histological type (adenocarcinoma and papillary) vs. others (signet ring/mucinous/adenosquamous) (p = 0.004), depth of tumor infiltration (p = 0.017), distant metastasis (p = 0.012), and adjuvant therapies (chemotherapy/radiotherapy) (p = 0.083) were associated with poor prognosis. Multivariate survival analysis showed histological type (p = 0.004) and distant metastasis (p = 0.032) to be independent prognostic factors for OS. Histological type (p = 0.002), distant metastasis (p = 0.003), and depth of tumor infiltration (T3-T4) (p = 0.012) showed poor median survival. Poor survival was seen in VEGF and HER2/neu positive cases. CONCLUSION: Overexpression of VEGF, PDGF-B, and HER2/neu might be possible prognostic biomarkers in GBC. Poor survival of VEGF and HER2/neu positive cases indicates the possibilities of using their blockers as therapeutic agents.


Asunto(s)
Neoplasias de la Vesícula Biliar , Humanos , Pronóstico , Neoplasias de la Vesícula Biliar/genética , Neoplasias de la Vesícula Biliar/terapia , Factor A de Crecimiento Endotelial Vascular , Estadificación de Neoplasias , Metástasis Linfática , Receptor ErbB-2/genética , Receptor ErbB-2/metabolismo
7.
Am J Surg ; 225(4): 630-638, 2023 04.
Artículo en Inglés | MEDLINE | ID: mdl-36424200

RESUMEN

INTRODUCTION: Mucinous cystic neoplasms (MCN) are mucin-producing epithelial cell tumors of pancreas. They consist of an ovarian-type stroma expressing estrogen and progesterone receptors. Pregnancy-associated MCNs are presumed to be larger in size and more aggressive without any concrete evidence. OBJECTIVE: and Data Sources: Systematic review of published literature using PubMed and Google Scholar databases. Original articles including case reports and series published between 1970&2021 were included wherein MCN was diagnosed during pregnancy/within one-year post-partum. Thirty-three publications having 36 cases, adding one of our own patient were analyzed in this review. RESULT: Median age at presentation was 32 years. Only three (9%) patients were asymptomatic. Mean size of MCN was 135 mm. Ten patients (27%) reported an increase in size during pregnancy. Most tumors involved body and tail of pancreas (60%). Distal pancreatectomy with splenectomy was the most common resection performed (57%). No foetal mortality was reported to date. CONCLUSION: Pregnancy may cause a rapid increase in size of MCN. Decision-making is more complex and needs a fine balance between optimal oncological and obstetric outcomes.


Asunto(s)
Cistadenocarcinoma Mucinoso , Neoplasias Quísticas, Mucinosas y Serosas , Neoplasias Pancreáticas , Femenino , Embarazo , Humanos , Adulto , Neoplasias Pancreáticas/patología , Neoplasias Quísticas, Mucinosas y Serosas/cirugía , Páncreas/cirugía , Pancreatectomía , Células Epiteliales/patología , Cistadenocarcinoma Mucinoso/cirugía
8.
J Clin Exp Hepatol ; 12(2): 503-509, 2022.
Artículo en Inglés | MEDLINE | ID: mdl-35535107

RESUMEN

Background: Proximal splenorenal shunt (PSRS) is one of the most commonly performed portosystemic shunt (PSS) in extrahepatic portal venous obstruction (EHPVO) for portal decompression. Sometimes various anatomical and surgical factors related to the splenic vein and/or left renal vein may make the construction of a PSRS difficult or impossible. Unconventional shunts are required to tide over such conditions. Methods: From January 2008 to December 2018, 189 patients with EHPVO underwent PSS, of which, the 10 patients who underwent unconventional shunts form the study group of this paper. Results: The ten unconventional shunts included 8 proximal splenoadrenal shunts, one collateral-renal shunt, and one inferior mesenteric vein to inferior vena cava (IMV-Caval) shunt. The mean percentage drop in omental pressure was 34.2% post-shunt with a mean anastomotic diameter of 13.7 ± 3.1 mm. Three patients experienced some form of postoperative complication. With a mean follow-up period of 32.3 months (maximum of 111 months) all patients had patent shunts on follow-up Doppler. None of the patients had variceal bleed, or features of biliopathy and hepatic encephalopathy in follow-up. Conclusion: Unconventional shunts can be used safely and effectively with good postoperative outcomes in EHPVO.

9.
Nat Rev Dis Primers ; 8(1): 69, 2022 10 27.
Artículo en Inglés | MEDLINE | ID: mdl-36302789

RESUMEN

Gallbladder cancer (GBC) is the most common cancer of the biliary tract, characterized by a very poor prognosis when diagnosed at advanced stages owing to its aggressive behaviour and limited therapeutic options. Early detection at a curable stage remains challenging because patients rarely exhibit symptoms; indeed, most GBCs are discovered incidentally following cholecystectomy for symptomatic gallbladder stones. Long-standing chronic inflammation is an important driver of GBC, regardless of the lithiasic or non-lithiasic origin. Advances in omics technologies have provided a deeper understanding of GBC pathogenesis, uncovering mechanisms associated with inflammation-driven tumour initiation and progression. Surgical resection is the only treatment with curative intent for GBC but very few cases are suitable for resection and most adjuvant therapy has a very low response rate. Several unmet clinical needs require to be addressed to improve GBC management, including discovery and validation of reliable biomarkers for screening, therapy selection and prognosis. Standardization of preneoplastic and neoplastic lesion nomenclature, as well as surgical specimen processing and sampling, now provides reproducible and comparable research data that provide a basis for identifying and implementing early detection strategies and improving drug discovery. Advances in the understanding of next-generation sequencing, multidisciplinary care for GBC, neoadjuvant and adjuvant strategies, and novel systemic therapies including chemotherapy and immunotherapies are gradually changing the treatment paradigm and prognosis of this recalcitrant cancer.


Asunto(s)
Neoplasias de la Vesícula Biliar , Cálculos Biliares , Humanos , Neoplasias de la Vesícula Biliar/diagnóstico , Neoplasias de la Vesícula Biliar/terapia , Neoplasias de la Vesícula Biliar/patología , Colecistectomía , Pronóstico , Inflamación
10.
Abdom Radiol (NY) ; 47(2): 554-565, 2022 02.
Artículo en Inglés | MEDLINE | ID: mdl-34851429

RESUMEN

The Gallbladder Reporting and Data System (GB-RADS) ultrasound (US) risk stratification is proposed to improve consistency in US interpretations, reporting, and assessment of risk of malignancy in gallbladder wall thickening in non-acute setting. It was developed based on a systematic review of the literature and the consensus of an international multidisciplinary committee comprising expert radiologists, gastroenterologists, gastrointestinal surgeons, surgical oncologists, medical oncologists, and pathologists using modified Delphi method. For risk stratification, the GB-RADS system recommends six categories (GB-RADS 0-5) of gallbladder wall thickening with gradually increasing risk of malignancy. GB-RADS is based on gallbladder wall features on US including symmetry and extent (focal vs. circumferential) of involvement, layered appearance, intramural features (including intramural cysts and echogenic foci), and interface with the liver. GB-RADS represents the first collaborative effort at risk stratifying the gallbladder wall thickening. This concept is in line with the other US-based risk stratification systems which have been shown to increase the accuracy of detection of malignant lesions and improve management.


Asunto(s)
Sistemas de Datos , Vesícula Biliar , Consenso , Vesícula Biliar/diagnóstico por imagen , Vesícula Biliar/patología , Humanos , Medición de Riesgo , Ultrasonografía
11.
NMR Biomed ; 24(4): 335-42, 2011 May.
Artículo en Inglés | MEDLINE | ID: mdl-22945290

RESUMEN

Qualitative and quantitative (1) H NMR analysis of lipid extracts of gallbladder tissue in chronic cholecystitis (CC, benign) (n = 14), xanthogranulomatous cholecystitis (XGC, intermediate) (n = 9) and gallbladder cancer (GBC, malignant) (n = 8) was carried out to understand the mechanisms involved in the transformation of benign gallbladder tissue to intermediate and malignant tissue. The results revealed alterations in various tissue lipid components in gallbladder in CC, XGC and GBC. The difference in the nature of lipid components in benign and malignant disease may aid in the identification of the biological pathways involved in the etiopathogenesis of GBC. This is the first study on lipid profiling of gallbladder tissue by (1) H NMR spectroscopy, and has possible implications for the development of future diagnostic approaches.


Asunto(s)
Neoplasias de la Vesícula Biliar/metabolismo , Vesícula Biliar/metabolismo , Vesícula Biliar/patología , Metabolismo de los Lípidos , Espectroscopía de Resonancia Magnética/métodos , Protones , Colecistitis/metabolismo , Ésteres del Colesterol/metabolismo , Granuloma/metabolismo , Humanos , Membrana Mucosa/metabolismo , Membrana Mucosa/patología , Fosfolípidos/metabolismo , Plasmalógenos/metabolismo , Triglicéridos/metabolismo , Xantomatosis/metabolismo
12.
Surg Today ; 41(5): 660-6, 2011 May.
Artículo en Inglés | MEDLINE | ID: mdl-21533938

RESUMEN

PURPOSE: Post-endoscopic retrograde cholangiopancreatography (ERCP) perforation usually resolves conservatively; however, intervention is sometimes needed, and there is a paucity of literature regarding the best management approach. We evaluated our experience of managing post-ERCP perforations to help define the role of surgery with percutaneous drainage (PCD). METHODS: A retrospective chart review revealed 14 cases of post-ERCP perforation with intra-abdominal sepsis referred for intervention. We analyzed data pertaining to clinical details, management, and outcome. RESULTS: There were 12 patients with duodenal perforation and 2 with biliary perforation. Most (10/14; 72%) had symptom onset within 48 h, but delayed diagnosis or referral resulted in a mean delay until intervention of 6.6 days (range 1-18 days). Computed tomography revealed localized collections in 9 (64%) patients. Seven patients with localized collections and no or minimal contrast leak underwent PCD and rest, and 7 underwent surgery. The indications for surgery were free perforation, generalized peritonitis, and major contrast leak. Overall morbidity was 50% and there was one early postoperative death, caused by severe sepsis. CONCLUSION: There should be a high index of suspicion of perforation when abdominal signs and symptoms develop after ERCP. Computed tomography is the investigation of choice for diagnosis and guiding therapy. With judicious selection of surgery or PCD based on clinical and imaging features, patients can be managed with acceptable morbidity and low mortality.


Asunto(s)
Sistema Biliar/lesiones , Colangiopancreatografia Retrógrada Endoscópica/efectos adversos , Drenaje/métodos , Duodeno/lesiones , Heridas Penetrantes/terapia , Adolescente , Adulto , Anciano , Niño , Femenino , Humanos , Masculino , Persona de Mediana Edad , Tomografía Computarizada por Rayos X , Heridas Penetrantes/cirugía , Adulto Joven
13.
Trop Gastroenterol ; 32(2): 117-21, 2011.
Artículo en Inglés | MEDLINE | ID: mdl-21922875

RESUMEN

BACKGROUND: Only a few studies address the financial impact of the management of bile duct injuries (BDI). This study was aimed to assess the cost of BDI sustained during cholecystectomy. METHODS: Patients who underwent surgical repair for post cholecystectomy BDI and due for routine follow up between August 2006 and September 2007 were called for an interview. RESULTS: 47 patients were interviewed. There were 39 (83%) women and 8 (17%) men. The median direct cost was US$ 1626 (451-11,009); 73,983 (20,521-500,910). The median indirect cost was US$ 312 (26-2,708); 14,196 (1,183-123,214). Total median cost was US$ 2,045 (488-12,369); 93,046 (22,204-562,790). The median total costs of management of BDI was 9.98 times the costs of a cholecystectomy at our centre (US$ 205); (9,328) and was 8.41 times the median monthly income of the patients (US$ 243); (11,057). CONCLUSIONS: Our results will help the hospital administrators and the insurance agencies to calculate and revise the packages and premium for cholecystectomy so that the extra cost of a possible BDI is evenly distributed.


Asunto(s)
Conductos Biliares/lesiones , Colecistectomía , Enfermedad Iatrogénica/economía , Adulto , Anciano , Conductos Biliares/cirugía , Femenino , Humanos , Entrevistas como Asunto , Masculino , Persona de Mediana Edad
14.
Asian Pac J Cancer Prev ; 22(2): 509-516, 2021 Feb 01.
Artículo en Inglés | MEDLINE | ID: mdl-33639667

RESUMEN

BACKGROUND: Typhoid (Salmonella typhi and paratyphi) carriers and gall bladder cancer (GBC) are endemic in northern India. Results of previous studies about association of typhoid carriers with GBC are inconsistent. We studied antibodies against Salmonella typhi and paratyphi in serum samples of patients with GBC. METHODS: We performed modified Widal test for antibodies against Salmonella typhi (Vi and O) and Salmonella paratyphi (AO and BO) antigens in patients with GBC (n=100), xanthogranulomatous cholecystitis (XGC, n=24), chronic cholecystitis (CC, n=200) and healthy controls (HC, n=200). RESULTS: Serum antibodies against Salmonella were more frequently positive in GBC (22%) and XGC (29%), particularly in males in age ≥50 years (GBC: 47% and XGC: 50%) vs. HC (0) (p <0.01). Vi antibody was more common in GBC (13%, OR:9.8) and XGC (8%, OR:5.9) than HC (2%). O antibody was more common in GBC (8%, OR: 8.6) and XGC (8%, OR: 9.0) than HC (1%). O antibody was also more common in males with GBC (12%) than CC (1%) and HC (1%) (P=0.02 and p <0.001, respectively). AO (6%) and BO (4%) antibodies were detected in GBC, particularly in males, than HC (0), (p <0.01). Salmonella antibodies were more frequent in GBC with GS than those without GS (50% vs. 20%, OR=3.94, P=0.01). CONCLUSIONS: Salmonella carrier state was more common in GBC and XGC, particularly in elderly males than HC. The Vi antibody was more common in GBC and XGC than HC. Salmonella infection was more common in GBC with GS than those without GS.


Asunto(s)
Anticuerpos Antibacterianos/sangre , Colecistitis/microbiología , Neoplasias de la Vesícula Biliar/microbiología , Infecciones por Salmonella/epidemiología , Salmonella paratyphi A/inmunología , Salmonella typhi/inmunología , Xantomatosis/microbiología , Adulto , Anciano , Estudios de Casos y Controles , Colecistitis/sangre , Colecistitis/complicaciones , Enfermedad Crónica , Femenino , Neoplasias de la Vesícula Biliar/sangre , Neoplasias de la Vesícula Biliar/patología , Humanos , Masculino , Persona de Mediana Edad , Infecciones por Salmonella/diagnóstico , Xantomatosis/sangre , Xantomatosis/complicaciones
15.
Ann Hepatobiliary Pancreat Surg ; 24(4): 469-476, 2020 Nov 30.
Artículo en Inglés | MEDLINE | ID: mdl-33234750

RESUMEN

BACKGROUNDS/AIMS: In the absence of national registry of laparoscopic cholecystectomy (LC) or its complications, it is impossible to determine incidence of bile duct injury (BDI) in India. We conducted an e-survey among practicing surgeons to determine prevalence and management patterns of BDI in India. Our hypothesis was that majority of surgeons would have experienced a BDI during LC despite large experience and that most surgeons who have a BDI tend to manage it themselves. METHODS: An 18-question e-survey of practicing laparoscopic surgeons in India was done. RESULTS: 278/727 (38%) surgeons responded. 240/278 (86%) respondents admitted to a BDI during LC and 179/230 (78%) affirmed to more than one BDI. A total of 728 BDIs were reported. 36/230 (15%) respondents experienced their first BDI even after >10 years of practice and 40% had their first BDI even after having performed >100 LCs. 161/201 (80%) of the respondents decided to manage the BDI themselves, including 56/99 (57%) non-biliary surgeons and 44/82 (54%) surgeons working in non-biliary center. 37/201 (18%) respondents admitted to having a mortality arising out of a BDI; the mortality rate of BDI was 37/728 (5%) in this survey. Only 13/201 (6%) respondents have experienced a medico-legal case related to a BDI during LC. CONCLUSIONS: Prevalence of BDI is high in India and occurs despite adequate experience and volume. Even inexperienced non-biliary surgeons working in non-biliary centers attempt to repair the BDI themselves. BDI is associated with significant mortality but litigation rates are fortunately low in India.

16.
Am Surg ; 75(12): 1157-60, 2009 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-19999903

RESUMEN

The incidence of bile duct injury (BDI) has increased after the introduction of laparoscopic cholecystectomy. A BDI can occur in the hands of experienced surgeons also. It can result in serious complications and may even cause death of the patient; it also has financial and legal implications. Proper training, sound surgical technique, and conversion to an open operation can prevent a large number of injuries. An injury that is missed during the operation manifests in the postoperative period as a bile leak and external biliary fistula or during the follow up as a biliary stricture. Management of a BDI depends on the nature of the bile duct injured, type of injury, and expertise available; it may range from simple subhepatic drainage to Roux-en-Y hepaticojejunostomy. Excellent results can be obtained when BDI is managed at a hepatobiliary center.


Asunto(s)
Conductos Biliares/lesiones , Colecistectomía Laparoscópica/efectos adversos , Complicaciones Intraoperatorias/cirugía , Conductos Biliares/patología , Fístula Biliar/etiología , Conducto Colédoco/lesiones , Constricción Patológica , Humanos
17.
HPB (Oxford) ; 11(8): 638-44, 2009 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-20495631

RESUMEN

BACKGROUND: There have been an increasing number of reports world-wide relating improved outcomes after pancreatic resections to high volumes thereby supporting the idea of centralization of pancreatic resectional surgery. To date there has been no collective attempt from India at addressing this issue. This cohort study analysed peri-operative outcomes after pancreatoduodenectomy (PD) at seven major Indian centres. MATERIALS AND METHODS: Between January 2005 and December 2007, retrospective data on PDs, including intra-operative and post-operative factors, were obtained from seven major centres for pancreatic surgery in India. RESULTS: Between January 2005 and December 2007, a total of 718 PDs were performed in India at the seven centres. The median number of PDs performed per year was 34 (range 9-54). The median number of PDs per surgeon per year was 16 (range 7-38). Ninety-four per cent of surgeries were performed for suspected malignancy in the pancreatic head and periampullary region. The median mortality rate per centre was four (range 2-5%). Wound infections were the commonest complication with a median incidence per centre of 18% (range 9.3-32.2%), and the median post-operative duration of hospital stay was 16 days (range 4-100 days). CONCLUSIONS: This is the first multi-centric report of peri-operative outcomes of PD from India. The results from these specialist centers are very acceptable, and appear to support the thrust towards centralization.

18.
Chin Clin Oncol ; 8(4): 33, 2019 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-31484488

RESUMEN

India is a high incidence area for gallbladder cancer (GBC) and contributes to about 10% of the global GBC burden. Within India, the incidence is high in North, North-East, Central and Eastern India, and less common in South and West India. The incidence has been on a steady rise in both genders. The presentation is often with advanced disease and carries dismal prognosis. GBC in India usually affects younger patients in the 5th and 6th decade in contrast to the west. Gallstones are present in 80% of the Indian patients with GBC and its presence increases the vulnerability of the GB to mucosal injury. The incidence of GBC is out of proportion to the prevalence of gallstones in the country. Additional co-factors such as older age, lower socio-economic status, chronic Salmonella typhi (S. typhi) infection, Helicobacter pylori (H. pylori) infection, exposure to pollutants, heavy metals, chemicals, adulterated mustard oil and smoking in patients with gallstones have been identified which promote carcinogenesis. These risk factors act in tandem in an additive manner resulting in higher incidence of GBC as well as hasten the development of GBC. Environmental risk factors such as soil and water contamination by industrial wastes, agricultural effluents and human sewage have been identified as putative risk factors. Combination of a toxic environment, vulnerable GB and a susceptible host play a key role in the pathogenesis of GBC in the country. Large multicentric comprehensive studies are required in India to assess the attributable risk of each of the identified putative risk factors. This will help in formulating cost effective national strategies in preventing GBC related mortality in the country. Meanwhile a high index of suspicion to pick up incidental GBC, and improved access to healthcare facilities to manage GS appropriately will help in reducing GBC related mortality.


Asunto(s)
Neoplasias de la Vesícula Biliar/epidemiología , Femenino , Humanos , India , Masculino
19.
Asian Pac J Cancer Prev ; 20(12): 3643-3647, 2019 Dec 01.
Artículo en Inglés | MEDLINE | ID: mdl-31870105

RESUMEN

BACKGROUND: Carcinogen metabolism pathway and tumor suppressor gene polymorphisms have been reported to be associated with increased gallbladder cancer risk. However, the association of genetic variants and gallbladder cancer risk in Indians are not well studied. We examined whether genetic polymorphisms of metabolic enzymes cytochrome P450 1A1 and glutathione S-transferase and tumor suppressor gene p53 (TP53) are associated with an increased risk of gallbladder cancer in North Indians. METHODS: This hospital-based case-control study was conducted in 96 gallbladder cancer patients with gallstones (cases) and 93 cholelithiasis patients (controls) at the Sanjay Gandhi Postgraduate Institute of Medical Sciences in Lucknow, India from July 2014 through May 2017. Genomic DNA was extracted from white blood cells of each patient using a simple salting-out procedure. The genotypic frequencies of CYP1A1 rs4646903, CYP1A1 rs1048943, and TP53 rs1042522 polymorphisms were investigated using TaqMan SNP Genotyping Assay and GSTM1 and GSTT1 polymorphisms were analyzed using the multiplex PCR assay. RESULTS: The frequency of CC genotype of TP53 rs1042522 polymorphism was 27.1% (26/96) in cases and 12.9% (12/93) in controls. The CC genotype was associated with an increased risk of gallbladder cancer in North Indians (age- and sex-adjusted odds ratio, 2.81; 95% confidence interval, 1.19-6.61; P = 0.02). No significant differences in genotypic and allelic frequencies of the metabolic pathway gene polymorphisms were found between cases and controls. CONCLUSIONS: Our data provide preliminary evidence that the CC genotype of the TP53 rs1042522 polymorphism may be associated with an increased risk of gallbladder cancer in North Indians.


Asunto(s)
Citocromo P-450 CYP1A1/genética , Neoplasias de la Vesícula Biliar/genética , Glutatión Transferasa/genética , Proteína p53 Supresora de Tumor/genética , Adulto , Anciano , Anciano de 80 o más Años , Estudios de Casos y Controles , Colelitiasis/patología , Femenino , Vesícula Biliar/patología , Neoplasias de la Vesícula Biliar/epidemiología , Cálculos Biliares/patología , Frecuencia de los Genes , Genes Supresores de Tumor , Predisposición Genética a la Enfermedad/genética , Humanos , India/epidemiología , Masculino , Persona de Mediana Edad , Polimorfismo de Nucleótido Simple/genética
20.
Anticancer Agents Med Chem ; 19(16): 2019-2033, 2019.
Artículo en Inglés | MEDLINE | ID: mdl-31345154

RESUMEN

BACKGROUND: The aberrant alteration in Jab1 signalosome (COP9 Signalosome Complex Subunit 5) has been proven to be associated with the progression of several carcinomas. However the specific role and mechanism of action of Jab1 signalosome in carcinogenesis of gall bladder cancer (GBC) are poorly understood. OBJECTIVE: The main objective of our study was to elucidate the role and mechanism of Jab1 signalosome in gall bladder cancer by employing siRNA. METHODS: Jab1 overexpression was identified in gall bladder cancer tissue sample. The role of Jab1-siRNA approach in cell growth inhibition and apoptotic induction was then examined by RT-PCR, Western Blotting, MTT, ROS, Hoechst and FITC/Annexin-V staining. RESULTS: In the current study, we have shown that overexpression of Jab1 stimulated the proliferation of GBC cells; whereas downregulation of Jab1 by using Jab1-siRNA approach resulted incell growth inhibition and apoptotic induction. Furthermore, we found that downregulation of Jab1 induces cell cycle arrest at G1 phase and upregulated the expression of p27, p53 and Bax gene. Moreover, Jab1-siRNA induces apoptosis by enhancing ROS generation and caspase-3 activation. In addition, combined treatment with Jab1-siRNA and gemicitabine demonstrated an enhanced decline in cell proliferation which further suggested increased efficacy of gemcitabine at a very lower dose (5µM) in combination with Jab1-siRNA. CONCLUSION: In conclusion, our study strongly suggests that targeting Jab1 signalosome could be a promising therapeutic target for the treatment of gall bladder cancer.


Asunto(s)
Complejo del Señalosoma COP9/genética , Proliferación Celular/genética , Neoplasias de la Vesícula Biliar/metabolismo , Silenciador del Gen , Péptidos y Proteínas de Señalización Intracelular/genética , Péptido Hidrolasas/genética , ARN Interferente Pequeño/genética , Ciclo Celular/genética , Neoplasias de la Vesícula Biliar/genética , Neoplasias de la Vesícula Biliar/patología , Humanos , Cultivo Primario de Células , Especies Reactivas de Oxígeno/metabolismo , Células Tumorales Cultivadas
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA